Sato T, Takahashi N, Tan-No K, Kisara K, Sakurada T, Sakurada S
Department of Pharmaceutics, Tohoku College of Pharmacy, Sendai, Japan.
Methods Find Exp Clin Pharmacol. 1998 Sep;20(7):581-6. doi: 10.1358/mf.1998.20.7.485722.
The antinociceptive properties of dermorphin tetrapeptide analog, H-Tyr-D-Arg-Phe-beta-Ala-OH (TDAPA) were compared with morphine in mice. In the tail-pressure test, subcutaneously (s.c.) injected TDAPA and morphine produced significant antinociceptive activity. Pretreatment with naloxonazine (35 mg/kg, s.c., 24 h before testing) significantly antagonized the activity induced by TDAPA, but not morphine. The ED50 values of TDAPA changed from 0.39 mg/kg to 1.7 mg/kg by naloxonazine pretreatment In the formalin test, both TDAPA and morphine exhibited dose-related antinociceptive activity with ED50 values of 0.49 mg/kg and 2.5 mg/kg, respectively. Both drug activities were significantly antagonized by naloxonazine. These results indicate different mechanisms of action for TDAPA and morphine, suggesting TDAPA is highly selective for the mu 1-opioid receptor and may be clinically useful.
在小鼠中,将皮肤吗啡四肽类似物H-Tyr-D-Arg-Phe-β-Ala-OH(TDAPA)的抗伤害感受特性与吗啡进行了比较。在尾压试验中,皮下注射TDAPA和吗啡均产生了显著的抗伤害感受活性。用纳洛嗪预处理(35mg/kg,皮下注射,测试前24小时)可显著拮抗TDAPA诱导的活性,但对吗啡无此作用。经纳洛嗪预处理后,TDAPA的半数有效剂量(ED50)值从0.39mg/kg变为1.7mg/kg。在福尔马林试验中,TDAPA和吗啡均表现出剂量相关的抗伤害感受活性,ED50值分别为0.49mg/kg和2.5mg/kg。两种药物的活性均被纳洛嗪显著拮抗。这些结果表明TDAPA和吗啡的作用机制不同,提示TDAPA对μ1阿片受体具有高度选择性,可能具有临床应用价值。